|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,610.00 INR | -1.15% |
|
+0.08% | -0.35% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.75 | 8.52 | 5.93 | 8.38 | 8.09 | |||||
Return on Total Capital | 12.04 | 10.44 | 7.38 | 10.71 | 10.37 | |||||
Return On Equity % | 23.33 | 20.48 | 11.01 | 17.98 | 19.14 | |||||
Return on Common Equity | 23.42 | 20.55 | 11.13 | 18.55 | 19.42 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 59.67 | 59.75 | 56.72 | 60.02 | 62.01 | |||||
SG&A Margin | 22.34 | 24.23 | 25.63 | 23.94 | 25.01 | |||||
EBITDA Margin % | 21.61 | 18.92 | 13.7 | 17.58 | 18.99 | |||||
EBITA Margin % | 19.08 | 16.55 | 11.53 | 15.68 | 16.71 | |||||
EBIT Margin % | 18.89 | 16.39 | 11.38 | 15.53 | 16.6 | |||||
Income From Continuing Operations Margin % | 18.25 | 15.8 | 8.68 | 14.3 | 17.09 | |||||
Net Income Margin % | 17.88 | 15.47 | 8.48 | 14.18 | 16.7 | |||||
Net Avail. For Common Margin % | 17.88 | 15.47 | 8.48 | 14.18 | 16.7 | |||||
Normalized Net Income Margin | 12.08 | 10.43 | 7.29 | 10.39 | 11.51 | |||||
Levered Free Cash Flow Margin | 13.94 | -5.72 | 4.79 | 24.53 | 4.9 | |||||
Unlevered Free Cash Flow Margin | 14.22 | -5.54 | 5.22 | 24.93 | 5.41 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.83 | 0.83 | 0.83 | 0.86 | 0.78 | |||||
Fixed Assets Turnover | 3.24 | 3.89 | 4.39 | 5 | 4.78 | |||||
Receivables Turnover (Average Receivables) | 5.44 | 6.09 | 5.75 | 5.72 | 5.41 | |||||
Inventory Turnover (Average Inventory) | 1.73 | 1.61 | 1.79 | 1.92 | 1.76 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.92 | 1.76 | 2.35 | 2.61 | 2.76 | |||||
Quick Ratio | 1.01 | 0.7 | 0.93 | 1.68 | 1.69 | |||||
Operating Cash Flow to Current Liabilities | 0.35 | 0.23 | 0.45 | 0.49 | 0.48 | |||||
Days Sales Outstanding (Average Receivables) | 67.04 | 59.98 | 63.44 | 63.99 | 67.47 | |||||
Days Outstanding Inventory (Average Inventory) | 210.89 | 226.73 | 204.03 | 190.39 | 206.88 | |||||
Average Days Payable Outstanding | 90.76 | 82.29 | 92.32 | 104.17 | 126.23 | |||||
Cash Conversion Cycle (Average Days) | 187.17 | 204.41 | 175.15 | 150.22 | 148.13 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 23.71 | 30.16 | 14.8 | 13.24 | 11.11 | |||||
Total Debt / Total Capital | 19.17 | 23.17 | 12.89 | 11.69 | 10 | |||||
LT Debt/Equity | 1.29 | 0.86 | 0.75 | 2.14 | 4.65 | |||||
Long-Term Debt / Total Capital | 1.04 | 0.66 | 0.65 | 1.89 | 4.19 | |||||
Total Liabilities / Total Assets | 34.39 | 37.12 | 31.41 | 31.21 | 29.72 | |||||
EBIT / Interest Expense | 42.01 | 56.43 | 16.31 | 24.48 | 20.54 | |||||
EBITDA / Interest Expense | 48.65 | 65.94 | 20 | 28.04 | 23.82 | |||||
(EBITDA - Capex) / Interest Expense | 43.76 | 54.97 | 17.12 | 24.81 | 17.37 | |||||
Total Debt / EBITDA | 0.92 | 1.31 | 0.86 | 0.63 | 0.55 | |||||
Net Debt / EBITDA | 0.02 | 0.67 | 0.16 | -1.27 | -1.09 | |||||
Total Debt / (EBITDA - Capex) | 1.03 | 1.57 | 1.01 | 0.71 | 0.76 | |||||
Net Debt / (EBITDA - Capex) | 0.02 | 0.8 | 0.18 | -1.43 | -1.5 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.24 | 19.96 | 9.08 | 9.21 | 2.34 | |||||
Gross Profit, 1 Yr. Growth % | 7.49 | 20.11 | 3.54 | 15.58 | 5.73 | |||||
EBITDA, 1 Yr. Growth % | 28.92 | 5.09 | -21.02 | 40.11 | 10.56 | |||||
EBITA, 1 Yr. Growth % | 31.66 | 4.11 | -23.99 | 48.44 | 9.11 | |||||
EBIT, 1 Yr. Growth % | 32.29 | 4.14 | -24.3 | 49.1 | 9.36 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 40.76 | 3.87 | -40.08 | 79.92 | 22.3 | |||||
Net Income, 1 Yr. Growth % | 40.63 | 3.82 | -40.19 | 82.47 | 20.59 | |||||
Normalized Net Income, 1 Yr. Growth % | 37.85 | 3.59 | -23.77 | 55.57 | 13.38 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 40.63 | 3.82 | -40.19 | 82.47 | 20.59 | |||||
Accounts Receivable, 1 Yr. Growth % | -2.56 | 17.47 | 13.57 | 6.59 | 9.72 | |||||
Inventory, 1 Yr. Growth % | 27.14 | 29.97 | -13.24 | 2.06 | 9.82 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.44 | 2.2 | -9.13 | 1.73 | 11.95 | |||||
Total Assets, 1 Yr. Growth % | 15.82 | 22.14 | -2.22 | 13.22 | 13.59 | |||||
Tangible Book Value, 1 Yr. Growth % | 21.77 | 18.35 | 4.78 | 15.02 | 16.36 | |||||
Common Equity, 1 Yr. Growth % | 19.74 | 17.1 | 4.72 | 14 | 16.22 | |||||
Cash From Operations, 1 Yr. Growth % | 116.19 | -12.17 | 51.44 | 15.78 | -1.81 | |||||
Capital Expenditures, 1 Yr. Growth % | -46.32 | 73.86 | -31.27 | 11.33 | 160.57 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -288.59 | -149.29 | -191.24 | 459.58 | -79.49 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -301.35 | -146.78 | -202.8 | 421.17 | -77.81 | |||||
Dividend Per Share, 1 Yr. Growth % | 20 | 13.33 | -26.47 | 60 | 12.5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 9.77 | 12.89 | 14.39 | 9.14 | 5.72 | |||||
Gross Profit, 2 Yr. CAGR % | 10.41 | 13.63 | 11.52 | 9.39 | 10.54 | |||||
EBITDA, 2 Yr. CAGR % | 30.38 | 16.37 | -8.89 | 5.2 | 24.46 | |||||
EBITA, 2 Yr. CAGR % | 33.35 | 17.05 | -11.04 | 6.22 | 27.26 | |||||
EBIT, 2 Yr. CAGR % | 33.36 | 17.34 | -11.21 | 6.24 | 27.7 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 44.61 | 20.91 | -21.11 | 3.83 | 48.34 | |||||
Net Income, 2 Yr. CAGR % | 44.37 | 20.83 | -21.2 | 4.46 | 48.33 | |||||
Normalized Net Income, 2 Yr. CAGR % | 35.29 | 19.5 | -11.14 | 8.9 | 32.81 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 44.37 | 20.83 | -21.2 | 4.46 | 48.33 | |||||
Accounts Receivable, 2 Yr. CAGR % | 13.46 | 6.99 | 15.5 | 10.02 | 8.14 | |||||
Inventory, 2 Yr. CAGR % | 24.17 | 28.55 | 6.19 | -5.9 | 5.87 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.05 | -0.15 | -3.63 | -3.85 | 6.72 | |||||
Total Assets, 2 Yr. CAGR % | 18.46 | 18.94 | 9.28 | 5.22 | 13.4 | |||||
Tangible Book Value, 2 Yr. CAGR % | 17.28 | 20.05 | 11.36 | 9.78 | 15.69 | |||||
Common Equity, 2 Yr. CAGR % | 16.46 | 18.41 | 10.73 | 9.26 | 15.11 | |||||
Cash From Operations, 2 Yr. CAGR % | 27.37 | 37.8 | 15.33 | 32.42 | 6.63 | |||||
Capital Expenditures, 2 Yr. CAGR % | -39.31 | -3.39 | 9.31 | -12.53 | 70.32 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 278.1 | -3.61 | -32.94 | 125.95 | 6.96 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 233.75 | -2.97 | -30.65 | 131.47 | 7.54 | |||||
Dividend Per Share, 2 Yr. CAGR % | 36.93 | 16.62 | -8.71 | 8.47 | 34.16 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.52 | 13.07 | 11.6 | 12.63 | 6.83 | |||||
Gross Profit, 3 Yr. CAGR % | 10.15 | 13.55 | 10.16 | 12.86 | 8.16 | |||||
EBITDA, 3 Yr. CAGR % | 23.11 | 21.32 | 2.27 | 5.16 | 6.95 | |||||
EBITA, 3 Yr. CAGR % | 23.53 | 22.77 | 1.36 | 5.51 | 7.18 | |||||
EBIT, 3 Yr. CAGR % | 23.49 | 22.79 | 1.39 | 5.53 | 7.27 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 36.33 | 29.5 | -4.32 | 3.84 | 9.65 | |||||
Net Income, 3 Yr. CAGR % | 35.94 | 29.34 | -4.42 | 4.25 | 9.58 | |||||
Normalized Net Income, 3 Yr. CAGR % | 22.38 | 23.77 | 2.87 | 7.1 | 10.37 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 35.94 | 29.34 | -4.42 | 4.25 | 9.58 | |||||
Accounts Receivable, 3 Yr. CAGR % | 14.15 | 14.78 | 9.14 | 12.45 | 9.92 | |||||
Inventory, 3 Yr. CAGR % | 17.04 | 26.07 | 12.76 | 4.79 | -0.93 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.28 | 2.1 | -3.23 | -1.88 | 1.15 | |||||
Total Assets, 3 Yr. CAGR % | 14.54 | 19.68 | 11.42 | 10.58 | 7.93 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.7 | 17.63 | 14.73 | 12.57 | 11.93 | |||||
Common Equity, 3 Yr. CAGR % | 14.89 | 16.67 | 13.66 | 11.81 | 11.53 | |||||
Cash From Operations, 3 Yr. CAGR % | 68.15 | 12.53 | 42.2 | 15.48 | 19.85 | |||||
Capital Expenditures, 3 Yr. CAGR % | -34.19 | -13.8 | -13.76 | 9.98 | 25.86 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 17.96 | 91.69 | -5.36 | 36.02 | 1.44 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 20.27 | 73.35 | -1.08 | 35.84 | 5.94 | |||||
Dividend Per Share, 3 Yr. CAGR % | 32.15 | 28.56 | 0 | 10.06 | 9.79 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 12.48 | 13.33 | 12.66 | 11.48 | 9.21 | |||||
Gross Profit, 5 Yr. CAGR % | 11.65 | 12.16 | 10.69 | 11.87 | 10.31 | |||||
EBITDA, 5 Yr. CAGR % | 17 | 15 | 9.13 | 14.59 | 10.63 | |||||
EBITA, 5 Yr. CAGR % | 16.4 | 14.09 | 8.31 | 15.86 | 11.02 | |||||
EBIT, 5 Yr. CAGR % | 16.38 | 14.05 | 8.21 | 15.88 | 11.19 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.55 | 13.18 | 9.54 | 18.55 | 14.03 | |||||
Net Income, 5 Yr. CAGR % | 16.41 | 13.03 | 9.3 | 18.75 | 13.95 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.65 | 13.58 | 7.67 | 17.59 | 13.94 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 16.41 | 13.03 | 9.3 | 18.75 | 13.95 | |||||
Accounts Receivable, 5 Yr. CAGR % | 23.15 | 21.48 | 14.69 | 12.86 | 8.74 | |||||
Inventory, 5 Yr. CAGR % | 20.52 | 20.04 | 12.57 | 12.15 | 9.95 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.6 | 10.31 | 2.2 | -0.32 | 0.63 | |||||
Total Assets, 5 Yr. CAGR % | 15.79 | 16.46 | 12.41 | 13.67 | 12.21 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.07 | 14.96 | 13.94 | 14.43 | 15.11 | |||||
Common Equity, 5 Yr. CAGR % | 14.85 | 14.09 | 13.21 | 13.65 | 14.24 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.75 | 18.72 | 44.61 | 20.1 | 26.73 | |||||
Capital Expenditures, 5 Yr. CAGR % | -5.4 | -12.07 | -19.38 | -13.3 | 13.22 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 35.1 | 34.67 | -5.9 | 104.72 | -0.61 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 39.91 | 29.99 | -3.51 | 94.6 | 2.28 | |||||
Dividend Per Share, 5 Yr. CAGR % | 18.76 | 17.78 | 13.97 | 20.11 | 12.47 |
- Stock Market
- Equities
- ALKEM Stock
- Financials Alkem Laboratories Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















